Uplizna

Medicinal product

(Invented) name

Uplizna

Active substance (s)

Inebilizumabas

Strength

100 mg

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AG10, inebilizumab

Marketing authorisation holder

Amgen Europe B.V., Nyderlandai

Date of authorisation

2022-04-25

Date of renewal

Documents

Uplizna paciento kortele.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	10 ml
Inebilizumabas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108678	94784	1094784	flakonas	10 ml N3		Receptinis	EU/1/21/1602/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-04-25	Registruotas